Biotechnology
The Biotechnology industry has a total of 590 stocks, with a combined market cap of $1.13 trillion and total revenue of $110.17 billion.
Market Cap
1.13T
Revenue
110.17B
Profits
-39.7B
PE Ratio
n/a
Profit Margin
-36.03%
Dividend Yield
0.04%
590 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 112.92B | 2.79% | 1,279,267 | 12.00B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 79.58B | 2.01% | 580,428 | 14.34B |
| 3 | ARGX | argenx SE | 48.76B | 2.57% | 316,499 | 4.24B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 43.40B | 2.42% | 1,024,695 | 3.71B |
| 5 | ONC | BeOne Medicines AG | 34.62B | 2.75% | 237,508 | 5.34B |
| 6 | INSM | Insmed Incorporated | 34.58B | -1.75% | 3,356,065 | 606.42M |
| 7 | RPRX | Royalty Pharma plc | 27.63B | 2.20% | 2,653,604 | 2.38B |
| 8 | BNTX | BioNTech SE | 23.29B | 2.74% | 569,530 | 3.37B |
| 9 | MRNA | Moderna, Inc. | 20.66B | 3.97% | 4,859,873 | 1.94B |
| 10 | ROIV | Roivant Sciences Ltd. | 20.16B | 1.51% | 3,732,289 | 13.31M |
| 11 | RVMD | Revolution Medicines, Inc. | 19.17B | 0.48% | 1,203,521 | - |
| 12 | INCY | Incyte Corporation | 19.08B | 2.35% | 1,152,023 | 5.14B |
| 13 | GMAB | Genmab A/S | 17.17B | 2.71% | 1,838,660 | 3.72B |
| 14 | SMMT | Summit Therapeutics Inc. | 14.58B | -2.13% | 2,088,787 | - |
| 15 | ASND | Ascendis Pharma A/S | 14.41B | 5.77% | 754,917 | 845.52M |
| 16 | BBIO | BridgeBio Pharma, Inc. | 14.37B | 3.07% | 1,441,432 | 502.08M |
| 17 | IONS | Ionis Pharmaceuticals, Inc. | 12.39B | 1.48% | 1,266,771 | 943.71M |
| 18 | JAZZ | Jazz Pharmaceuticals plc | 12.06B | 2.61% | 1,017,397 | 4.27B |
| 19 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.92B | 1.54% | 345,605 | 958.40M |
| 20 | EXEL | Exelixis, Inc. | 11.48B | 0.48% | 2,629,277 | 2.32B |
| 21 | BMRN | BioMarin Pharmaceutical Inc. | 11.00B | 1.74% | 1,561,196 | 3.22B |
| 22 | ABVX | ABIVAX Société Anonyme | 9.35B | 2.13% | 438,838 | 5.37M |
| 23 | ARWR | Arrowhead Pharmaceuticals, Inc. | 9.01B | 5.20% | 1,839,290 | 1.09B |
| 24 | PRAX | Praxis Precision Medicines, Inc. | 8.92B | 4.41% | 328,555 | 7.46M |
| 25 | AXSM | Axsome Therapeutics, Inc. | 8.86B | 2.64% | 524,925 | 638.50M |
| 26 | PCVX | Vaxcyte, Inc. | 8.65B | -0.97% | 1,511,453 | - |
| 27 | TECH | Bio-Techne Corporation | 8.64B | 2.56% | 2,011,250 | 1.22B |
| 28 | NUVL | Nuvalent, Inc. | 8.26B | 2.73% | 370,481 | - |
| 29 | CYTK | Cytokinetics, Incorporated | 8.10B | 0.44% | 1,755,975 | 88.04M |
| 30 | KRYS | Krystal Biotech, Inc. | 7.78B | 0.09% | 298,393 | 389.13M |
| 31 | HALO | Halozyme Therapeutics, Inc. | 7.75B | 2.88% | 1,670,755 | 1.40B |
| 32 | IBRX | ImmunityBio, Inc. | 7.21B | 1.75% | 16,541,532 | 113.29M |
| 33 | KYMR | Kymera Therapeutics, Inc. | 7.11B | 2.39% | 514,353 | 39.21M |
| 34 | BLTE | Belite Bio, Inc | 7.03B | 5.27% | 163,965 | - |
| 35 | ACLX | Arcellx, Inc. | 6.74B | -0.01% | 629,428 | 22.29M |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 6.51B | -1.60% | 819,198 | 46.02M |
| 37 | APGE | Apogee Therapeutics, Inc. | 6.14B | -0.19% | 788,280 | - |
| 38 | CNTA | Centessa Pharmaceuticals plc | 6.11B | -0.05% | 3,464,023 | 15.00M |
| 39 | TERN | Terns Pharmaceuticals, Inc. | 6.08B | 0.08% | 12,994,123 | - |
| 40 | COGT | Cogent Biosciences, Inc. | 5.95B | 3.73% | 2,228,789 | - |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 5.91B | 2.40% | 702,862 | 521.31M |
| 42 | PTCT | PTC Therapeutics, Inc. | 5.90B | 2.41% | 907,063 | 1.73B |
| 43 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.84B | -1.36% | 981,645 | 189.76M |
| 44 | CGON | CG Oncology, Inc. | 5.82B | -1.35% | 1,219,405 | 4.04M |
| 45 | SRRK | Scholar Rock Holding Corporation | 5.74B | 0.18% | 1,204,807 | - |
| 46 | CELC | Celcuity Inc. | 5.65B | 1.19% | 562,050 | - |
| 47 | CAI | Caris Life Sciences, Inc. | 5.51B | 4.05% | 1,533,824 | 812.03M |
| 48 | XENE | Xenon Pharmaceuticals Inc. | 5.49B | -0.19% | 819,723 | 7.50M |
| 49 | ERAS | Erasca, Inc. | 5.26B | -0.70% | 3,840,407 | - |
| 50 | APLS | Apellis Pharmaceuticals, Inc. | 5.20B | -0.02% | 4,584,173 | 1.00B |
| 51 | TGTX | TG Therapeutics, Inc. | 5.05B | 2.46% | 1,639,041 | 616.29M |
| 52 | IMVT | Immunovant, Inc. | 5.03B | 0.49% | 1,326,740 | - |
| 53 | CRSP | CRISPR Therapeutics AG | 4.97B | 4.14% | 1,723,540 | 3.51M |
| 54 | DNTH | Dianthus Therapeutics, Inc. | 4.63B | 1.48% | 1,033,306 | 2.04M |
| 55 | FOLD | Amicus Therapeutics, Inc. | 4.54B | -0.07% | 2,982,764 | 634.21M |
| 56 | CORT | Corcept Therapeutics Incorporated | 4.45B | 0.43% | 1,607,270 | 761.41M |
| 57 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.18B | 4.04% | 1,355,079 | 7.70M |
| 58 | LGND | Ligand Pharmaceuticals Incorporated | 4.15B | 1.46% | 233,279 | 268.09M |
| 59 | SYRE | Spyre Therapeutics, Inc. | 4.08B | 1.52% | 1,043,910 | - |
| 60 | NAMS | NewAmsterdam Pharma Company N.V. | 3.91B | 0.29% | 954,650 | 22.50M |
| 61 | VKTX | Viking Therapeutics, Inc. | 3.90B | -0.09% | 1,794,272 | - |
| 62 | ACAD | ACADIA Pharmaceuticals Inc. | 3.85B | 2.13% | 1,640,624 | 1.07B |
| 63 | GPCR | Structure Therapeutics Inc. | 3.76B | -2.87% | 852,360 | - |
| 64 | EWTX | Edgewise Therapeutics, Inc. | 3.54B | 1.66% | 681,629 | - |
| 65 | LEGN | Legend Biotech Corporation | 3.38B | 1.72% | 2,267,661 | 1.03B |
| 66 | TLX | Telix Pharmaceuticals Limited | 3.26B | 1.56% | 103,739 | 803.79M |
| 67 | DNLI | Denali Therapeutics Inc. | 3.11B | 1.08% | 1,116,426 | - |
| 68 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.09B | 1.28% | 1,347,261 | 588.99M |
| 69 | ORKA | Oruka Therapeutics, Inc. | 3.07B | 2.33% | 1,545,994 | - |
| 70 | TARS | Tarsus Pharmaceuticals, Inc. | 3.06B | 4.55% | 497,055 | 451.36M |
| 71 | ARQT | Arcutis Biotherapeutics, Inc. | 3.05B | 5.76% | 1,170,000 | 376.07M |
| 72 | DYN | Dyne Therapeutics, Inc. | 3.03B | 1.21% | 1,121,507 | - |
| 73 | TVTX | Travere Therapeutics, Inc. | 2.93B | 0.03% | 1,198,481 | 490.73M |
| 74 | ALMS | Alumis Inc. | 2.89B | 1.79% | 1,285,857 | 24.05M |
| 75 | VERA | Vera Therapeutics, Inc. | 2.88B | 0.82% | 1,223,152 | - |
| 76 | TNGX | Tango Therapeutics, Inc. | 2.86B | 1.31% | 2,453,105 | 62.38M |
| 77 | RCUS | Arcus Biosciences, Inc. | 2.84B | 2.63% | 1,060,944 | 247.00M |
| 78 | SLNO | Soleno Therapeutics, Inc. | 2.72B | 0.48% | 14,092,194 | 190.41M |
| 79 | IDYA | IDEAYA Biosciences, Inc. | 2.72B | 0.16% | 1,704,620 | 218.71M |
| 80 | RLAY | Relay Therapeutics, Inc. | 2.59B | 7.64% | 5,620,992 | 15.36M |
| 81 | KOD | Kodiak Sciences Inc. | 2.58B | 0.02% | 891,951 | - |
| 82 | ELVN | Enliven Therapeutics, Inc. | 2.57B | -0.53% | 1,199,766 | - |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.54B | 3.38% | 1,776,803 | 1.55M |
| 84 | IRON | Disc Medicine, Inc. | 2.53B | -0.87% | 334,533 | - |
| 85 | BEAM | Beam Therapeutics Inc. | 2.53B | 3.88% | 1,852,695 | 139.74M |
| 86 | IMNM | Immunome, Inc. | 2.45B | 0.56% | 1,339,558 | 6.94M |
| 87 | ZLAB | Zai Lab Limited | 2.41B | 1.86% | 1,071,047 | 460.16M |
| 88 | AAPG | Ascentage Pharma Group International | 2.40B | -2.82% | 983 | 82.08M |
| 89 | ADMA | ADMA Biologics, Inc. | 2.34B | 6.16% | 5,538,378 | 510.17M |
| 90 | SRPT | Sarepta Therapeutics, Inc. | 2.30B | -5.11% | 2,717,562 | 2.20B |
| 91 | MLYS | Mineralys Therapeutics, Inc. | 2.29B | -1.94% | 837,288 | - |
| 92 | ADPT | Adaptive Biotechnologies Corporation | 2.29B | 8.24% | 2,188,851 | 276.98M |
| 93 | RARE | Ultragenyx Pharmaceutical Inc. | 2.27B | - | 1,615,498 | 673.00M |
| 94 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | -0.09% | 1,522,672 | 158.18M |
| 95 | MANE | Veradermics, Incorporated | 2.17B | 2.35% | 439,570 | - |
| 96 | SNDX | Syndax Pharmaceuticals, Inc. | 2.17B | -0.32% | 1,730,151 | 172.35M |
| 97 | NKTR | Nektar Therapeutics | 2.15B | -1.52% | 756,140 | 55.23M |
| 98 | AUPH | Aurinia Pharmaceuticals Inc. | 2.11B | 0.63% | 843,951 | 283.06M |
| 99 | DFTX | Definium Therapeutics, Inc. | 2.10B | 2.14% | 1,277,303 | - |
| 100 | STOK | Stoke Therapeutics, Inc. | 2.06B | 3.23% | 1,245,922 | 184.42M |
| 101 | TYRA | Tyra Biosciences, Inc. | 2.00B | -1.59% | 857,684 | - |
| 102 | AGIO | Agios Pharmaceuticals, Inc. | 1.98B | -3.82% | 1,236,137 | 54.03M |
| 103 | ZYME | Zymeworks Inc. | 1.97B | 2.73% | 1,043,267 | 105.97M |
| 104 | GLPG | Galapagos NV | 1.89B | -0.14% | 92,737 | 1.31B |
| 105 | ANAB | AnaptysBio, Inc. | 1.88B | 5.49% | 565,659 | 234.60M |
| 106 | MESO | Mesoblast Limited | 1.85B | 1.68% | 344,970 | 65.38M |
| 107 | OCUL | Ocular Therapeutix, Inc. | 1.83B | 0.96% | 4,028,946 | 51.95M |
| 108 | CAPR | Capricor Therapeutics, Inc. | 1.82B | -1.16% | 639,979 | 11.13M |
| 109 | PHVS | Pharvaris N.V. | 1.80B | -1.01% | 202,429 | - |
| 110 | RXRX | Recursion Pharmaceuticals, Inc. | 1.79B | 6.27% | 15,676,952 | 74.68M |
| 111 | PVLA | Palvella Therapeutics, Inc. | 1.76B | 2.62% | 280,434 | - |
| 112 | INVA | Innoviva, Inc. | 1.75B | 1.46% | 650,159 | 411.33M |
| 113 | VCEL | Vericel Corporation | 1.73B | 2.10% | 493,627 | 276.26M |
| 114 | TRVI | Trevi Therapeutics, Inc. | 1.68B | -0.23% | 1,077,368 | - |
| 115 | SION | Sionna Therapeutics, Inc. | 1.66B | 0.52% | 274,361 | - |
| 116 | HRMY | Harmony Biosciences Holdings, Inc. | 1.65B | 3.08% | 887,688 | 868.45M |
| 117 | NTLA | Intellia Therapeutics, Inc. | 1.64B | 2.36% | 3,015,570 | 67.67M |
| 118 | OCS | Oculis Holding AG | 1.62B | 3.56% | 145,668 | 1.51M |
| 119 | IMCR | Immunocore Holdings plc | 1.61B | -0.34% | 488,625 | 400.02M |
| 120 | NRIX | Nurix Therapeutics, Inc. | 1.61B | -4.59% | 2,005,201 | 71.78M |
| 121 | RAPP | Rapport Therapeutics, Inc. | 1.61B | 0.60% | 136,548 | - |
| 122 | NUVB | Nuvation Bio Inc. | 1.55B | 0.44% | 3,394,806 | 62.90M |
| 123 | DMRA | Damora Therapeutics, Inc. | 1.54B | 4.92% | 151,308 | - |
| 124 | GENB | Generate Biomedicines, Inc. | 1.52B | 0.93% | 390,153 | 31.89M |
| 125 | VIR | Vir Biotechnology, Inc. | 1.52B | 3.82% | 2,512,437 | 68.56M |
| 126 | SVRA | Savara Inc. | 1.50B | 2.77% | 1,183,163 | - |
| 127 | MBX | MBX Biosciences, Inc. | 1.50B | 4.87% | 453,999 | - |
| 128 | ARDX | Ardelyx, Inc. | 1.50B | 2.52% | 3,052,815 | 407.32M |
| 129 | VRDN | Viridian Therapeutics, Inc. | 1.48B | 3.65% | 4,593,416 | 70.85M |
| 130 | NBTX | Nanobiotix S.A. | 1.47B | 2.22% | 93,102 | 38.27M |
| 131 | PGEN | Precigen, Inc. | 1.46B | - | 5,499,712 | 9.68M |
| 132 | IOVA | Iovance Biotherapeutics, Inc. | 1.43B | 4.52% | 15,629,660 | 263.50M |
| 133 | BCAX | Bicara Therapeutics Inc. | 1.41B | 1.50% | 340,569 | - |
| 134 | IMTX | Immatics N.V. | 1.41B | 2.73% | 406,692 | 56.67M |
| 135 | BHVN | Biohaven Ltd. | 1.41B | 1.30% | 1,256,295 | - |
| 136 | MAZE | Maze Therapeutics, Inc. | 1.40B | -0.85% | 927,080 | 2.50M |
| 137 | NVAX | Novavax, Inc. | 1.37B | 5.51% | 3,730,130 | 1.12B |
| 138 | ATAI | AtaiBeckley Inc. | 1.37B | -0.79% | 5,094,431 | 4.09M |
| 139 | GLUE | Monte Rosa Therapeutics, Inc. | 1.37B | - | 1,151,924 | 123.67M |
| 140 | OLMA | Olema Pharmaceuticals, Inc. | 1.37B | 2.89% | 925,454 | - |
| 141 | WVE | Wave Life Sciences Ltd. | 1.34B | - | 2,457,432 | 42.73M |
| 142 | MLTX | MoonLake Immunotherapeutics | 1.33B | 8.90% | 1,839,318 | - |
| 143 | TSHA | Taysha Gene Therapies, Inc. | 1.31B | -0.44% | 2,314,926 | 9.77M |
| 144 | CRVS | Corvus Pharmaceuticals, Inc. | 1.25B | 3.69% | 681,583 | - |
| 145 | ZBIO | Zenas BioPharma, Inc. | 1.24B | -7.21% | 837,212 | 10.00M |
| 146 | PHAR | Pharming Group N.V. | 1.21B | 3.41% | 25,285 | 376.13M |
| 147 | DBVT | DBV Technologies S.A. | 1.19B | 5.18% | 118,791 | 5.64M |
| 148 | EYPT | EyePoint, Inc. | 1.18B | 4.42% | 1,084,778 | 31.37M |
| 149 | AVBP | ArriVent BioPharma, Inc. | 1.12B | 0.24% | 489,648 | - |
| 150 | SEPN | Septerna, Inc. | 1.10B | -1.41% | 162,439 | 45.95M |
| 151 | GERN | Geron Corporation | 1.10B | -1.72% | 20,090,979 | 183.88M |
| 152 | MPLT | MapLight Therapeutics, Inc. | 1.07B | 0.41% | 390,340 | - |
| 153 | ABCL | AbCellera Biologics Inc. | 1.04B | 3.94% | 2,466,194 | 75.13M |
| 154 | XERS | Xeris Biopharma Holdings, Inc. | 1.02B | 0.85% | 2,340,786 | 291.85M |
| 155 | IVA | Inventiva S.A. | 1.02B | -0.75% | 226,695 | 9.31M |
| 156 | QURE | uniQure N.V. | 993.59M | -7.29% | 1,452,006 | 16.10M |
| 157 | KALV | KalVista Pharmaceuticals, Inc. | 987.06M | -4.22% | 840,708 | 73.62M |
| 158 | INBX | Inhibrx Biosciences, Inc. | 980.57M | 7.67% | 334,202 | 1.30M |
| 159 | EVMN | Evommune, Inc. | 977.18M | 9.44% | 439,199 | 13.00M |
| 160 | CMPX | Compass Therapeutics, Inc. | 972.47M | 1.69% | 3,059,872 | 850.00K |
| 161 | ANNX | Annexon, Inc. | 970.87M | 1.00% | 2,468,283 | - |
| 162 | AKTS | Aktis Oncology, Inc. | 938.59M | 1.56% | 215,515 | 6.50M |
| 163 | PHAT | Phathom Pharmaceuticals, Inc. | 930.61M | 2.25% | 920,982 | 175.11M |
| 164 | URGN | UroGen Pharma Ltd. | 929.83M | 5.93% | 817,186 | 109.79M |
| 165 | GHRS | GH Research PLC | 929.82M | 2.11% | 60,348 | - |
| 166 | CTMX | CytomX Therapeutics, Inc. | 918.75M | -1.16% | 6,317,795 | 76.20M |
| 167 | ORIC | ORIC Pharmaceuticals, Inc. | 908.24M | 2.03% | 1,695,368 | - |
| 168 | CGEM | Cullinan Therapeutics, Inc. | 905.47M | 0.67% | 611,622 | - |
| 169 | FTRE | Fortrea Holdings Inc. | 900.41M | 1.26% | 1,130,578 | 2.72B |
| 170 | XNCR | Xencor, Inc. | 898.40M | -0.49% | 974,757 | 125.58M |
| 171 | JANX | Janux Therapeutics, Inc. | 883.88M | -2.68% | 704,177 | 10.00M |
| 172 | SLS | SELLAS Life Sciences Group, Inc. | 872.77M | 7.76% | 4,098,085 | - |
| 173 | SANA | Sana Biotechnology, Inc. | 856.64M | 1.90% | 2,081,671 | - |
| 174 | ABUS | Arbutus Biopharma Corporation | 856.19M | -1.79% | 1,967,821 | 14.08M |
| 175 | TBPH | Theravance Biopharma, Inc. | 854.78M | 0.24% | 285,394 | 107.46M |
| 176 | VOR | Vor Biopharma Inc. | 853.15M | -6.56% | 1,824,577 | - |
| 177 | OMER | Omeros Corporation | 828.68M | 4.83% | 1,191,210 | - |
| 178 | JBIO | Jade Biosciences, Inc. | 826.54M | 2.44% | 502,098 | - |
| 179 | SPRY | ARS Pharmaceuticals, Inc. | 813.24M | 0.49% | 1,831,087 | 84.28M |
| 180 | DRUG | Bright Minds Biosciences Inc. | 805.65M | 7.66% | 259,034 | - |
| 181 | MNKD | MannKind Corporation | 804.14M | 1.56% | 4,471,318 | 348.97M |
| 182 | MRVI | Maravai LifeSciences Holdings, Inc. | 799.48M | 7.61% | 1,850,508 | 185.74M |
| 183 | SLDB | Solid Biosciences Inc. | 789.10M | 3.62% | 644,341 | - |
| 184 | DSGN | Design Therapeutics, Inc. | 781.39M | 3.68% | 312,585 | - |
| 185 | KURA | Kura Oncology, Inc. | 776.42M | -0.34% | 1,046,034 | 67.48M |
| 186 | MGTX | MeiraGTx Holdings plc | 764.78M | -1.26% | 804,333 | 81.39M |
| 187 | TENX | Tenax Therapeutics, Inc. | 757.02M | 3.15% | 526,994 | - |
| 188 | SGP | SpyGlass Pharma, Inc. | 742.74M | 5.46% | 147,973 | - |
| 189 | RLMD | Relmada Therapeutics, Inc. | 735.27M | 3.85% | 683,707 | - |
| 190 | ARVN | Arvinas, Inc. | 717.00M | -1.41% | 700,335 | 262.60M |
| 191 | LXRX | Lexicon Pharmaceuticals, Inc. | 707.55M | 4.37% | 2,303,384 | 49.80M |
| 192 | ANRO | Alto Neuroscience, Inc. | 693.54M | 1.69% | 267,544 | - |
| 193 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 691.48M | 2.86% | 421,276 | - |
| 194 | ALLO | Allogene Therapeutics, Inc. | 658.20M | 3.05% | 3,578,071 | 22.00K |
| 195 | LBRX | LB Pharmaceuticals Inc | 657.27M | 2.69% | 181,876 | - |
| 196 | GYRE | Gyre Therapeutics, Inc. | 647.42M | -0.42% | 93,177 | 116.59M |
| 197 | DRTS | Alpha Tau Medical Ltd. | 633.67M | 0.84% | 348,148 | - |
| 198 | OCGN | Ocugen, Inc. | 628.49M | 6.90% | 4,656,719 | 4.41M |
| 199 | PRME | Prime Medicine, Inc. | 626.86M | 3.81% | 1,732,064 | 4.63M |
| 200 | CBIO | Crescent Biopharma, Inc. | 608.48M | -4.63% | 126,393 | 10.84M |
| 201 | MDXG | MiMedx Group, Inc. | 589.81M | 2.85% | 1,648,206 | 418.63M |
| 202 | PRTA | Prothena Corporation plc | 573.32M | 2.80% | 454,454 | 9.68M |
| 203 | CRMD | CorMedix Inc. | 571.53M | 0.84% | 883,094 | 311.71M |
| 204 | TECX | Tectonic Therapeutic, Inc. | 564.43M | 3.51% | 160,975 | - |
| 205 | ZVRA | Zevra Therapeutics, Inc. | 563.04M | -0.93% | 568,274 | 106.47M |
| 206 | PROK | ProKidney Corp. | 558.54M | 1.09% | 695,939 | 893.00K |
| 207 | KYTX | Kyverna Therapeutics, Inc. | 557.40M | -1.18% | 911,182 | - |
| 208 | RIGL | Rigel Pharmaceuticals, Inc. | 549.21M | 3.48% | 385,388 | 294.28M |
| 209 | ACRS | Aclaris Therapeutics, Inc. | 549.03M | 5.33% | 873,276 | 7.83M |
| 210 | VALN | Valneva SE | 546.53M | 5.04% | 44,208 | 205.07M |
| 211 | ZURA | Zura Bio Limited | 540.82M | 0.88% | 645,086 | - |
| 212 | UPB | Upstream Bio, Inc. | 535.49M | 1.44% | 474,364 | 2.85M |
| 213 | LYEL | Lyell Immunopharma, Inc. | 534.45M | 5.19% | 72,246 | 36.00K |
| 214 | LRMR | Larimar Therapeutics, Inc. | 528.76M | 0.99% | 1,322,382 | - |
| 215 | FULC | Fulcrum Therapeutics, Inc. | 526.14M | 0.89% | 553,356 | 80.00M |
| 216 | FDMT | 4D Molecular Therapeutics, Inc. | 515.62M | -1.37% | 631,238 | 85.21M |
| 217 | TRDA | Entrada Therapeutics, Inc. | 515.52M | 3.39% | 157,182 | 25.42M |
| 218 | EIKN | Eikon Therapeutics, Inc. | 514.32M | 8.20% | 459,222 | - |
| 219 | STTK | Shattuck Labs, Inc. | 502.38M | 3.54% | 431,975 | 1.00M |
| 220 | FBRX | Forte Biosciences, Inc. | 493.04M | 0.38% | 157,099 | - |
| 221 | ENGN | enGene Holdings Inc. | 489.69M | -0.27% | 117,706 | - |
| 222 | REPL | Replimune Group, Inc. | 485.94M | -24.55% | 6,345,127 | - |
| 223 | AGMB | AgomAb Therapeutics NV | 480.06M | -6.28% | 182,630 | - |
| 224 | VSTM | Verastem, Inc. | 478.70M | - | 1,215,471 | 30.91M |
| 225 | CTNM | Contineum Therapeutics, Inc. | 477.53M | 0.47% | 135,024 | - |
| 226 | VTVT | vTv Therapeutics Inc. | 477.27M | 0.55% | 79,685 | 17.00K |
| 227 | LXEO | Lexeo Therapeutics, Inc. | 477.12M | 2.06% | 1,039,428 | - |
| 228 | ADCT | ADC Therapeutics SA | 473.88M | 0.27% | 541,620 | 81.36M |
| 229 | AVIR | Atea Pharmaceuticals, Inc. | 472.46M | -0.67% | 408,862 | - |
| 230 | ASMB | Assembly Biosciences, Inc. | 465.57M | 2.87% | 115,746 | 72.30M |
| 231 | IMMX | Immix Biopharma, Inc. | 463.86M | -3.74% | 512,694 | - |
| 232 | ABSI | Absci Corporation | 457.53M | 2.40% | 3,208,402 | 2.80M |
| 233 | STRO | Sutro Biopharma, Inc. | 448.14M | 5.21% | 221,478 | 102.48M |
| 234 | RGNX | REGENXBIO Inc. | 447.52M | -1.48% | 587,385 | 170.44M |
| 235 | ARMP | Armata Pharmaceuticals, Inc. | 443.99M | 1.42% | 113,425 | 4.90M |
| 236 | ANL | Adlai Nortye Ltd. | 443.91M | 22.76% | 1,341,726 | -1.35M |
| 237 | ALT | Altimmune, Inc. | 438.45M | -0.30% | 1,695,749 | 41.00K |
| 238 | AURA | Aura Biosciences, Inc. | 434.30M | 2.11% | 349,129 | - |
| 239 | VNDA | Vanda Pharmaceuticals Inc. | 430.90M | -2.15% | 1,198,527 | 216.11M |
| 240 | EPRX | Eupraxia Pharmaceuticals Inc. | 420.16M | 1.62% | 140,266 | - |
| 241 | XOMA | XOMA Royalty Corporation | 413.00M | 0.23% | 183,387 | 52.15M |
| 242 | IPSC | Century Therapeutics, Inc. | 411.57M | 1.33% | 1,283,340 | 109.16M |
| 243 | YDES | YD Bio Limited | 405.04M | -17.48% | 20,458 | 510.36K |
| 244 | DNA | Ginkgo Bioworks Holdings, Inc. | 400.47M | 0.88% | 751,065 | 170.16M |
| 245 | ENTA | Enanta Pharmaceuticals, Inc. | 399.60M | 2.53% | 76,940 | 66.98M |
| 246 | NMRA | Neumora Therapeutics, Inc. | 396.85M | 2.35% | 1,280,409 | - |
| 247 | AUTL | Autolus Therapeutics plc | 396.55M | 9.56% | 1,823,882 | 75.39M |
| 248 | NAUT | Nautilus Biotechnology, Inc. | 396.15M | 0.32% | 349,822 | - |
| 249 | RCKT | Rocket Pharmaceuticals, Inc. | 392.84M | 3.45% | 2,374,637 | - |
| 250 | PRTC | PureTech Health plc | 391.19M | 1.03% | 2,773 | 6.39M |
| 251 | MNPR | Monopar Therapeutics Inc. | 388.34M | 8.24% | 98,078 | - |
| 252 | LCTX | Lineage Cell Therapeutics, Inc. | 383.59M | 1.32% | 1,209,895 | 14.56M |
| 253 | PBYI | Puma Biotechnology, Inc. | 382.08M | 7.75% | 463,631 | 228.37M |
| 254 | IVVD | Invivyd, Inc. | 381.79M | 4.65% | 2,749,651 | 53.43M |
| 255 | BNTC | Benitec Biopharma Inc. | 378.86M | 1.37% | 92,286 | - |
| 256 | RZLT | Rezolute, Inc. | 369.78M | 7.88% | 2,110,986 | - |
| 257 | NAGE | Niagen Bioscience, Inc. | 369.14M | 2.91% | 608,875 | 129.42M |
| 258 | XFOR | X4 Pharmaceuticals, Inc. | 368.22M | 8.58% | 1,073,811 | 35.11M |
| 259 | IRD | Opus Genetics, Inc. | 366.42M | 4.67% | 725,135 | 14.20M |
| 260 | CADL | Candel Therapeutics, Inc. | 362.57M | - | 826,380 | - |
| 261 | IMRX | Immuneering Corporation | 355.59M | 5.16% | 518,422 | - |
| 262 | PRLD | Prelude Therapeutics Incorporated | 348.30M | -4.09% | 397,807 | 12.14M |
| 263 | BCYC | Bicycle Therapeutics plc | 347.14M | 1.63% | 238,438 | 72.59M |
| 264 | CABA | Cabaletta Bio, Inc. | 343.99M | 0.65% | 1,429,013 | - |
| 265 | OVID | Ovid Therapeutics Inc. | 342.87M | 1.56% | 4,747,655 | 7.25M |
| 266 | CLYM | Climb Bio, Inc. | 339.15M | 3.35% | 363,893 | - |
| 267 | NGEN | NervGen Pharma Corp. | 338.29M | 5.29% | 380,015 | - |
| 268 | NGNE | Neurogene Inc. | 336.56M | 3.35% | 89,410 | 925.00K |
| 269 | GLSI | Greenwich LifeSciences, Inc. | 335.28M | 7.51% | 196,071 | - |
| 270 | DMAC | DiaMedica Therapeutics Inc. | 333.53M | -5.50% | 208,475 | - |
| 271 | AVTX | Avalo Therapeutics, Inc. | 328.38M | -9.48% | 1,576,968 | 59.00K |
| 272 | ACIU | AC Immune SA | 318.44M | 3.22% | 507,830 | 4.51M |
| 273 | PALI | Palisade Bio, Inc. | 313.08M | -2.09% | 1,844,582 | - |
| 274 | SRZN | Surrozen, Inc. | 297.85M | 0.62% | 67,517 | 3.48M |
| 275 | IKT | Inhibikase Therapeutics, Inc. | 296.53M | -1.14% | 701,695 | 1.00 |
| 276 | LENZ | LENZ Therapeutics, Inc. | 296.30M | -2.68% | 492,071 | 19.09M |
| 277 | FHTX | Foghorn Therapeutics Inc. | 287.04M | -1.61% | 152,481 | 30.91M |
| 278 | CCCC | C4 Therapeutics, Inc. | 282.98M | 5.84% | 1,642,611 | 35.95M |
| 279 | NBP | NovaBridge Biosciences | 282.46M | -1.21% | 1,803,034 | - |
| 280 | TARA | Protara Therapeutics, Inc. | 282.32M | 1.56% | 431,157 | - |
| 281 | AVXL | Anavex Life Sciences Corp. | 281.72M | -1.30% | 1,022,308 | - |
| 282 | ABEO | Abeona Therapeutics Inc. | 277.83M | 1.25% | 626,835 | 5.82M |
| 283 | SLN | Silence Therapeutics plc | 276.32M | 4.46% | 288,948 | 559.00K |
| 284 | PLYX | Polaryx Therapeutics, Inc. | 271.75M | 11.24% | 147,720 | - |
| 285 | EDIT | Editas Medicine, Inc. | 270.13M | 0.73% | 1,058,707 | 40.52M |
| 286 | ALEC | Alector, Inc. | 267.08M | -2.02% | 340,364 | 21.05M |
| 287 | ADAG | Adagene Inc. | 264.29M | -9.71% | 967,941 | 7.67M |
| 288 | HELP | Cybin Inc. | 262.69M | - | 427,568 | - |
| 289 | SABS | SAB Biotherapeutics, Inc. | 262.13M | -0.80% | 201,160 | 114.70K |
| 290 | CLLS | Cellectis S.A. | 262.12M | 5.65% | 9,861 | 79.59M |
| 291 | CHRS | Coherus Oncology, Inc. | 254.81M | 1.80% | 816,740 | 42.17M |
| 292 | OBIO | Orchestra BioMed Holdings, Inc. | 249.88M | 0.23% | 112,036 | 33.48M |
| 293 | ALXO | ALX Oncology Holdings Inc. | 249.40M | 3.55% | 442,394 | - |
| 294 | KROS | Keros Therapeutics, Inc. | 247.46M | 2.53% | 349,901 | 244.06M |
| 295 | SLGL | Sol-Gel Technologies Ltd. | 243.54M | 4.77% | 155,802 | 19.39M |
| 296 | CNTX | Context Therapeutics Inc. | 242.56M | 0.76% | 434,567 | - |
| 297 | ARCT | Arcturus Therapeutics Holdings Inc. | 241.60M | -0.12% | 637,021 | 82.03M |
| 298 | CAMP | Camp4 Therapeutics Corporation | 237.79M | -1.51% | 39,079 | 3.50M |
| 299 | ELDN | Eledon Pharmaceuticals, Inc. | 237.77M | 2.62% | 1,358,543 | - |
| 300 | NERV | Minerva Neurosciences, Inc. | 234.55M | 4.63% | 342,930 | - |
| 301 | VYGR | Voyager Therapeutics, Inc. | 233.63M | -1.01% | 639,127 | 40.37M |
| 302 | FENC | Fennec Pharmaceuticals Inc. | 223.74M | 2.69% | 156,682 | 44.64M |
| 303 | MDWD | MediWound Ltd. | 221.96M | 1.77% | 110,046 | 16.96M |
| 304 | ENLV | Enlivex Ltd. | 221.50M | 11.96% | 1,492,276 | - |
| 305 | OABI | OmniAb, Inc. | 220.07M | 0.66% | 339,375 | 18.67M |
| 306 | MGNX | MacroGenics, Inc. | 219.27M | 2.99% | 1,217,987 | 149.50M |
| 307 | MIST | Milestone Pharmaceuticals Inc. | 218.32M | 10.56% | 3,348,433 | 1.55M |
| 308 | CGEN | Compugen Ltd. | 216.53M | -1.29% | 294,588 | 72.76M |
| 309 | NVCT | Nuvectis Pharma, Inc. | 215.64M | 2.65% | 55,711 | - |
| 310 | MENS | Jyong Biotech Ltd. | 206.09M | 5.93% | 130,302 | - |
| 311 | CDXS | Codexis, Inc. | 200.82M | 11.62% | 2,206,265 | 70.39M |
| 312 | ZNTL | Zentalis Pharmaceuticals, Inc. | 195.77M | 3.37% | 701,851 | 26.87M |
| 313 | KRRO | Korro Bio, Inc. | 194.13M | -3.24% | 129,662 | 6.39M |
| 314 | PRQR | ProQR Therapeutics N.V. | 192.81M | 7.65% | 930,790 | 19.19M |
| 315 | CRBU | Caribou Biosciences, Inc. | 188.44M | 4.84% | 1,072,886 | 11.16M |
| 316 | ELTX | Elicio Therapeutics, Inc. | 186.35M | 0.40% | 201,555 | - |
| 317 | ABOS | Acumen Pharmaceuticals, Inc. | 186.31M | -1.90% | 375,589 | - |
| 318 | CNTN | Canton Strategic Holdings, Inc. | 185.83M | 4.79% | 378,595 | - |
| 319 | TNXP | Tonix Pharmaceuticals Holding Corp. | 185.24M | -0.23% | 572,483 | 13.11M |
| 320 | SGMT | Sagimet Biosciences Inc. | 182.15M | 10.04% | 516,742 | - |
| 321 | PLX | Protalix BioTherapeutics, Inc. | 181.29M | 2.74% | 867,793 | 52.74M |
| 322 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 174.53M | 1.34% | 204,292 | - |
| 323 | ACHV | Achieve Life Sciences, Inc. | 173.56M | 1.87% | 320,618 | - |
| 324 | NKTX | Nkarta, Inc. | 164.68M | 2.67% | 285,211 | - |
| 325 | KPTI | Karyopharm Therapeutics Inc. | 163.44M | 0.55% | 487,250 | 146.07M |
| 326 | RNAC | Cartesian Therapeutics, Inc. | 163.03M | -2.07% | 152,536 | 2.80M |
| 327 | UNCY | Unicycive Therapeutics, Inc. | 162.78M | -3.44% | 557,625 | - |
| 328 | TLSA | Tiziana Life Sciences Ltd | 162.08M | 0.79% | 184,864 | - |
| 329 | AGEN | Agenus Inc. | 161.27M | 3.45% | 1,301,468 | 114.20M |
| 330 | WHWK | Whitehawk Therapeutics, Inc. | 160.94M | -0.58% | 212,634 | 7.15M |
| 331 | MOLN | Molecular Partners AG | 158.23M | 9.56% | 2,283 | 856.30K |
| 332 | SPRO | Spero Therapeutics, Inc. | 157.46M | 1.87% | 426,785 | 66.80M |
| 333 | TNYA | Tenaya Therapeutics, Inc. | 157.37M | 8.63% | 3,701,754 | - |
| 334 | HRTX | Heron Therapeutics, Inc. | 156.86M | 5.40% | 1,234,088 | 154.90M |
| 335 | IMUX | Immunic, Inc. | 155.25M | - | 1,309,884 | - |
| 336 | DTIL | Precision BioSciences, Inc. | 154.56M | -4.31% | 421,388 | 34.26M |
| 337 | ARTV | Artiva Biotherapeutics, Inc. | 153.00M | -7.20% | 156,731 | 251.00K |
| 338 | CNTB | Connect Biopharma Holdings Limited | 148.65M | -6.74% | 483,740 | 64.00K |
| 339 | GALT | Galectin Therapeutics Inc. | 146.14M | 1.37% | 517,457 | - |
| 340 | KLRS | Kalaris Therapeutics, Inc. | 145.37M | -1.86% | 114,342 | - |
| 341 | HUMA | Humacyte, Inc. | 144.65M | 7.35% | 4,717,408 | 2.04M |
| 342 | ACOG | Alpha Cognition Inc. | 144.47M | -4.67% | 84,450 | 10.22M |
| 343 | BDTX | Black Diamond Therapeutics, Inc. | 143.22M | 2.04% | 990,939 | 70.00M |
| 344 | ORMP | Oramed Pharmaceuticals Inc. | 140.75M | -1.14% | 82,746 | 2.00M |
| 345 | FATE | Fate Therapeutics, Inc. | 137.19M | 2.61% | 1,092,182 | 6.65M |
| 346 | IPHA | Innate Pharma S.A. | 130.95M | 7.41% | 20,243 | 10.57M |
| 347 | NTHI | NeOnc Technologies Holdings, Inc. | 127.84M | -7.73% | 70,424 | 39.99K |
| 348 | BMEA | Biomea Fusion, Inc. | 127.25M | -7.37% | 4,263,926 | - |
| 349 | ANTX | AN2 Therapeutics, Inc. | 120.04M | 1.21% | 214,606 | - |
| 350 | GNLX | Genelux Corporation | 117.14M | -0.38% | 229,013 | 8.00K |
| 351 | HURA | TuHURA Biosciences, Inc. | 115.08M | 22.71% | 1,250,018 | - |
| 352 | PEPG | PepGen Inc. | 114.73M | -0.60% | 996,546 | - |
| 353 | EQ | Equillium, Inc. | 113.81M | -6.25% | 362,523 | 4.39M |
| 354 | CBUS | Cibus, Inc. | 111.59M | -7.86% | 1,253,598 | 3.64M |
| 355 | CRDF | Cardiff Oncology, Inc. | 106.65M | - | 885,069 | 593.00K |
| 356 | SGMO | Sangamo Therapeutics, Inc. | 105.52M | -0.55% | 5,529,642 | 39.55M |
| 357 | ONCY | Oncolytics Biotech Inc. | 105.20M | 0.66% | 783,340 | - |
| 358 | TTRX | Turn Therapeutics Inc. | 104.26M | 4.17% | 17,654 | - |
| 359 | KZIA | Kazia Therapeutics Limited | 103.98M | -5.41% | 286,719 | 1.27M |
| 360 | VRCA | Verrica Pharmaceuticals Inc. | 99.98M | - | 119,025 | 35.58M |
| 361 | COYA | Coya Therapeutics, Inc. | 96.41M | 3.01% | 171,343 | 7.95M |
| 362 | PMN | ProMIS Neurosciences, Inc. | 95.95M | -1.65% | 24,164 | - |
| 363 | SEER | Seer, Inc. | 95.35M | - | 120,000 | 16.58M |
| 364 | ALDX | Aldeyra Therapeutics, Inc. | 94.49M | 3.29% | 1,333,567 | - |
| 365 | PYXS | Pyxis Oncology, Inc. | 92.36M | 0.68% | 197,319 | 13.86M |
| 366 | ANIX | Anixa Biosciences, Inc. | 91.53M | 1.49% | 130,927 | - |
| 367 | LONA | LeonaBio, Inc. | 89.99M | -17.98% | 90,974 | - |
| 368 | VANI | Vivani Medical, Inc. | 89.73M | - | 76,286 | - |
| 369 | INO | Inovio Pharmaceuticals, Inc. | 88.94M | 3.81% | 2,993,817 | 65.34K |
| 370 | EXOZ | eXoZymes, Inc. | 88.61M | 4.40% | 3,004 | -700.00 |
| 371 | SPRB | Spruce Biosciences, Inc. | 87.33M | 2.41% | 139,474 | 697.00K |
| 372 | AARD | Aardvark Therapeutics, Inc. | 85.74M | -2.72% | 149,329 | - |
| 373 | PLRX | Pliant Therapeutics, Inc. | 84.20M | 3.82% | 298,890 | - |
| 374 | MCRB | Seres Therapeutics, Inc. | 83.98M | -1.02% | 43,322 | 789.00K |
| 375 | CSBR | Champions Oncology, Inc. | 83.74M | -1.79% | 3,485 | 57.95M |
| 376 | OKYO | OKYO Pharma Limited | 83.44M | -0.63% | 108,372 | - |
| 377 | RANI | Rani Therapeutics Holdings, Inc. | 82.88M | 1.65% | 869,606 | 1.63M |
| 378 | FLNA | Filana Therapeutics, Inc. | 82.12M | 1.80% | 258,965 | - |
| 379 | ESLA | Estrella Immunopharma, Inc. | 81.92M | 11.63% | 593,302 | - |
| 380 | GOSS | Gossamer Bio, Inc. | 81.53M | 5.37% | 6,916,409 | 48.47M |
| 381 | PYPD | PolyPid Ltd. | 80.72M | 2.67% | 59,428 | - |
| 382 | QTTB | Q32 Bio Inc. | 80.02M | -7.29% | 202,311 | 53.74M |
| 383 | NRXS | NeurAxis, Inc. | 79.43M | -3.27% | 137,550 | 3.57M |
| 384 | CGTX | Cognition Therapeutics, Inc. | 78.65M | 7.68% | 915,721 | - |
| 385 | ATYR | aTyr Pharma, Inc. | 78.42M | 0.59% | 686,108 | 190.00K |
| 386 | IBIO | iBio, Inc. | 77.38M | 6.16% | 781,969 | 300.00K |
| 387 | PTHS | Pelthos Therapeutics Inc. | 76.84M | 0.70% | 18,799 | 16.80M |
| 388 | ATHE | Alterity Therapeutics Limited | 76.76M | 3.70% | 13,103 | 4.43M |
| 389 | IBO | Impact BioMedical Inc. | 76.55M | 6.07% | 321,966 | 32.00K |
| 390 | GANX | Gain Therapeutics, Inc. | 76.04M | -2.70% | 610,574 | - |
| 391 | MAIA | MAIA Biotechnology, Inc. | 75.23M | 3.33% | 621,820 | - |
| 392 | FBIO | Fortress Biotech, Inc. | 74.39M | -1.70% | 612,777 | 63.26M |
| 393 | NRXP | NRx Pharmaceuticals, Inc. | 74.33M | 0.90% | 703,344 | 1.23M |
| 394 | GUTS | Fractyl Health, Inc. | 73.79M | 3.26% | 1,273,472 | 3.00K |
| 395 | BYSI | BeyondSpring Inc. | 72.37M | 2.33% | 20,605 | 1.88M |
| 396 | XBIT | XBiotech Inc. | 71.34M | 2.18% | 29,244 | - |
| 397 | MNOV | MediciNova, Inc. | 70.88M | 1.41% | 33,430 | 409.66K |
| 398 | ACET | Adicet Bio, Inc. | 70.41M | 1.87% | 274,305 | - |
| 399 | IFRX | InflaRx N.V. | 68.68M | -1.78% | 298,258 | 34.44K |
| 400 | CING | Cingulate Inc. | 68.03M | -1.52% | 420,725 | - |
| 401 | COEP | Coeptis Therapeutics Holdings, Inc. | 67.52M | 3.73% | 64,934 | 1.36M |
| 402 | PMVP | PMV Pharmaceuticals, Inc. | 66.66M | -3.10% | 318,739 | - |
| 403 | ANVS | Annovis Bio, Inc. | 65.22M | 1.32% | 300,749 | - |
| 404 | DWTX | Dogwood Therapeutics, Inc. | 64.80M | -3.96% | 82,061 | - |
| 405 | TCRX | TScan Therapeutics, Inc. | 60.32M | -0.93% | 962,170 | 10.33M |
| 406 | OKUR | OnKure Therapeutics, Inc. | 59.89M | 2.10% | 121,029 | - |
| 407 | ACRV | Acrivon Therapeutics, Inc. | 59.28M | 4.08% | 503,640 | - |
| 408 | TIL | Instil Bio, Inc. | 57.92M | 1.07% | 36,430 | - |
| 409 | ICCC | ImmuCell Corporation | 57.72M | -3.33% | 36,973 | 27.64M |
| 410 | HYFT | MindWalk Holdings Corp. | 55.63M | 1.82% | 264,631 | 20.70M |
| 411 | INKT | MiNK Therapeutics, Inc. | 55.37M | -3.88% | 47,003 | - |
| 412 | PDSB | PDS Biotechnology Corporation | 55.26M | 7.84% | 1,610,089 | - |
| 413 | GRCE | Grace Therapeutics, Inc. | 55.24M | 7.21% | 823,471 | - |
| 414 | ENTX | Entera Bio Ltd. | 54.55M | - | 45,442 | 42.00K |
| 415 | KZR | Kezar Life Sciences, Inc. | 54.40M | -0.14% | 112,772 | - |
| 416 | EDSA | Edesa Biotech, Inc. | 52.96M | -1.49% | 173,653 | - |
| 417 | OSTX | OS Therapies Incorporated | 52.55M | 1.63% | 639,196 | - |
| 418 | RADX | Radiopharm Theranostics Limited | 52.53M | 2.99% | 30,925 | 10.86M |
| 419 | MGX | Metagenomi Therapeutics, Inc. | 52.29M | 2.21% | 184,605 | 25.21M |
| 420 | IMA | ImageneBio, Inc. | 51.12M | -3.79% | 19,633 | 800.00K |
| 421 | MREO | Mereo BioPharma Group plc | 50.95M | -2.33% | 1,128,740 | 500.00K |
| 422 | XLO | Xilio Therapeutics, Inc. | 50.25M | 2.24% | 60,964 | 43.77M |
| 423 | ALGS | Aligos Therapeutics, Inc. | 49.44M | 1.14% | 50,788 | 2.19M |
| 424 | HOWL | Werewolf Therapeutics, Inc. | 47.84M | -1.56% | 390,675 | 1.14M |
| 425 | NTRB | Nutriband Inc. | 47.65M | -2.00% | 6,219 | 2.28M |
| 426 | IMMP | Immutep Limited | 46.81M | -0.82% | 794,489 | 5.28M |
| 427 | TELO | Telomir Pharmaceuticals, Inc. | 45.73M | 0.76% | 52,007 | - |
| 428 | ACTU | Actuate Therapeutics, Inc. | 45.53M | -9.43% | 89,177 | - |
| 429 | LSTA | Lisata Therapeutics, Inc. | 45.16M | - | 16,936 | 170.00K |
| 430 | RNTX | Rein Therapeutics Inc. | 44.02M | -0.63% | 283,552 | - |
| 431 | RLYB | Rallybio Corporation | 43.48M | 2.11% | 116,534 | 858.00K |
| 432 | SNSE | Sensei Biotherapeutics, Inc. | 42.50M | 5.03% | 31,586 | - |
| 433 | RNXT | RenovoRx, Inc. | 42.30M | 4.33% | 138,140 | 1.12M |
| 434 | ATOS | Atossa Therapeutics, Inc. | 41.51M | -1.23% | 76,982 | - |
| 435 | LITS | Lite Strategy, Inc. | 41.45M | 0.88% | 168,738 | - |
| 436 | ATRA | Atara Biotherapeutics, Inc. | 40.97M | 6.37% | 121,569 | 120.77M |
| 437 | VERU | Veru Inc. | 40.93M | 2.82% | 114,752 | 16.89M |
| 438 | NXTC | NextCure, Inc. | 39.73M | 0.27% | 44,395 | - |
| 439 | CELU | Celularity Inc. | 39.51M | -1.44% | 26,274 | 40.58M |
| 440 | CRVO | CervoMed Inc. | 37.41M | 5.21% | 49,413 | 4.01M |
| 441 | HYPD | Hyperion DeFi, Inc. | 36.57M | 4.56% | 171,329 | 813.46K |
| 442 | ATNM | Actinium Pharmaceuticals, Inc. | 36.48M | - | 138,492 | 90.00K |
| 443 | CVM | CEL-SCI Corporation | 35.53M | 3.78% | 47,337 | - |
| 444 | ABVC | ABVC BioPharma, Inc. | 35.09M | -2.07% | 117,642 | 797.92K |
| 445 | INMB | INmune Bio Inc. | 34.29M | 1.57% | 368,564 | 50.00K |
| 446 | PTN | Palatin Technologies, Inc. | 34.13M | 2.11% | 12,765 | 8.96M |
| 447 | EVAX | Evaxion A/S | 33.86M | 6.84% | 15,129 | 7.53M |
| 448 | PLUR | Pluri Inc. | 33.77M | -1.03% | 4,313 | 1.34M |
| 449 | LIXT | Lixte Biotechnology Holdings, Inc. | 33.11M | - | 31,209 | - |
| 450 | LGVN | Longeveron Inc. | 33.09M | -2.59% | 1,378,806 | 1.20M |
| 451 | APLM | Apollomics, Inc. | 33.07M | 5.12% | 7,853 | 6.93M |
| 452 | DYAI | Dyadic International, Inc. | 32.53M | 1.50% | 12,113 | 3.09M |
| 453 | BCTX | BriaCell Therapeutics Corp. | 31.99M | - | 93,550 | - |
| 454 | PASG | Passage Bio, Inc. | 29.80M | 13.02% | 59,116 | - |
| 455 | KYNB | Kyntra Bio, Inc. | 29.54M | 5.49% | 13,038 | 6.44M |
| 456 | TVRD | Tvardi Therapeutics, Inc. | 28.61M | 7.02% | 73,404 | - |
| 457 | DARE | Daré Bioscience, Inc. | 26.94M | 4.52% | 83,759 | 1.03M |
| 458 | IGC | IGC Pharma, Inc. | 26.83M | 3.51% | 745,749 | 1.11M |
| 459 | CUE | Cue Biopharma, Inc. | 26.74M | 45.48% | 41,153,677 | 27.47M |
| 460 | SNTI | Senti Biosciences, Inc. | 26.54M | -0.92% | 115,318 | 22.00K |
| 461 | OTLK | Outlook Therapeutics, Inc. | 26.16M | 17.42% | 17,524,385 | 205.70K |
| 462 | BOLD | Boundless Bio, Inc. | 25.77M | 0.88% | 58,169 | - |
| 463 | XCUR | Exicure, Inc. | 25.69M | 4.95% | 8,459 | 500.00K |
| 464 | NRSN | NeuroSense Therapeutics Ltd. | 25.49M | -5.13% | 99,023 | - |
| 465 | NEUP | Neuphoria Therapeutics Inc. | 25.34M | 2.17% | 47,841 | 14.99M |
| 466 | SER | Serina Therapeutics, Inc. | 24.87M | -2.88% | 201,498 | 130.00K |
| 467 | MRKR | Marker Therapeutics, Inc. | 24.34M | 5.04% | 138,629 | 3.55M |
| 468 | TVGN | Tevogen Bio Holdings Inc. | 24.19M | 16.67% | 40,719 | - |
| 469 | BRNS | Barinthus Biotherapeutics plc | 24.07M | 8.91% | 25,244 | 14.97M |
| 470 | LEXX | Lexaria Bioscience Corp. | 23.77M | -3.52% | 137,187 | 522.00K |
| 471 | NNVC | NanoViricides, Inc. | 23.75M | 1.85% | 268,549 | - |
| 472 | SKYE | Skye Bioscience, Inc. | 23.61M | 0.17% | 160,250 | - |
| 473 | AEON | AEON Biopharma, Inc. | 22.77M | -4.00% | 83,816 | - |
| 474 | TPST | Tempest Therapeutics, Inc. | 22.38M | - | 152,322 | - |
| 475 | CRIS | Curis, Inc. | 21.82M | -0.73% | 1,401,450 | 9.44M |
| 476 | VTGN | Vistagen Therapeutics, Inc. | 21.80M | 2.69% | 383,195 | 789.00K |
| 477 | PSTV | Plus Therapeutics, Inc. | 21.75M | 8.56% | 1,040,486 | 5.21M |
| 478 | LTRN | Lantern Pharma Inc. | 21.75M | 10.23% | 359,529 | - |
| 479 | QNTM | Quantum BioPharma Ltd. | 20.84M | -5.15% | 254,249 | - |
| 480 | VYNE | VYNE Therapeutics Inc. | 20.33M | 2.87% | 95,603 | 570.00K |
| 481 | COCP | Cocrystal Pharma, Inc. | 19.85M | -2.04% | 680,257 | - |
| 482 | JSPR | Jasper Therapeutics, Inc. | 19.80M | 5.88% | 698,944 | - |
| 483 | KTTA | Pasithea Therapeutics Corp. | 19.10M | -4.01% | 97,105 | - |
| 484 | CTXR | Citius Pharmaceuticals, Inc. | 18.57M | 5.18% | 270,812 | 3.94M |
| 485 | ALLR | Allarity Therapeutics, Inc. | 18.35M | - | 55,018 | 320.00K |
| 486 | PLRZ | Polyrizon Ltd. | 18.33M | 1.99% | 24,113 | - |
| 487 | ICU | SeaStar Medical Holding Corporation | 16.69M | 0.24% | 64,639 | 1.23M |
| 488 | GNTA | Genenta Science S.p.A. | 16.69M | 2.15% | 46,468 | - |
| 489 | OSRH | OSR Holdings, Inc. | 16.30M | 0.14% | 765,143 | 2.91M |
| 490 | LPCN | Lipocine Inc. | 15.55M | 6.50% | 1,840,380 | 1.98M |
| 491 | PHIO | Phio Pharmaceuticals Corp. | 15.10M | 4.84% | 139,747 | - |
| 492 | HIND | Vyome Holdings, Inc. | 14.95M | 0.95% | 12,577 | 319.71K |
| 493 | INAB | IN8bio, Inc. | 14.28M | 1.40% | 45,130 | - |
| 494 | INTS | Intensity Therapeutics, Inc. | 13.97M | 4.76% | 36,444 | - |
| 495 | TOVX | Theriva Biologics, Inc. | 13.63M | 19.04% | 11,391,344 | - |
| 496 | JUNS | Jupiter Neurosciences, Inc. | 13.51M | 6.40% | 55,184 | 21.80K |
| 497 | BCDA | BioCardia, Inc. | 13.24M | 1.68% | 166,026 | 3.00K |
| 498 | MBRX | Moleculin Biotech, Inc. | 12.97M | 0.83% | 83,436 | - |
| 499 | GTBP | GT Biopharma, Inc. | 12.77M | -2.08% | 472,232 | - |
| 500 | TRAW | Traws Pharma, Inc. | 12.47M | -2.50% | 55,516 | 2.85M |